4.2 Article

Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex

Journal

PARASITOLOGY INTERNATIONAL
Volume 64, Issue 3, Pages 295-300

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.parint.2014.09.011

Keywords

Malaria; Plasmodium; Atovaquone-resistance; Cytochrome bc(1) complex

Categories

Funding

  1. Indonesian government through the Ministry of Research and Technology
  2. Japan Society for the Promotion of Sciences (JSPS) [26253025]
  3. Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry
  4. JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) [10000284]
  5. Grants-in-Aid for Scientific Research [26253025] Funding Source: KAKEN

Ask authors/readers for more resources

Atovaquone, a coenzyme Qanalogue has been indicated to specifically target the cytochrome bc(1) complex of the mitochondrial respiratory chain in the malarial parasite and other protozoan. Various mutations in the quinone binding site of the cytochrome b gene of Plasmodium spp. such as M1331, L144S, L271V, K272R, Y268C, Y268S, Y268N, and V284F are suggesting to associate with resistance to atovaquone. There is no direct evidence of relation between the mutations and resistance to atovaquone in Plasmodium parasite that has been available. Technical difficulties in isolating active assayable mitochondria in the malarial parasite hinder us to obtain direct biochemical evidence to support the relation between the mutations and drug resistance. The establishment of a mitochondrial isolation method for the malaria parasite has allowed us to test the degree of resistance of Plasmodium berghei isolates to atovaquone directly. We have tested the activity of dihydroorotate (DHO)-cytochrome c reductase in various P. berghei atovaquone resistant clones in the presence of a wide concentration range of atovaquone. Our results show the IC50 of P. berghei atovaquone resistant clones is much higher (1.5 up to 40 nM) in comparison to the atovaquone sensitive clones (0.132-0.465 nM). The highest IC50 was revealed in clones carrying Y268C and Y268N mutations (which play an important role in atovaquone resistance in Plasmodium falciparum), with an approximately 100-fold increase. The findings indicate the importance of the mutation in the quinone binding site of the cytochrome b gene and that provide a direct evidence for the atovaquone inhibitory mechanism in the cytochrome bc(1) complex of the parasite. (C) 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available